In this video by ALS Society of Canada, meet Dr. Michael Strong, a pioneer in ALS research with more than 20 years’ experience. Watch him comment on where your donated dollars go in research and the achievements of his lab at Western University. Learn more about ALS…
OptiKey is a free, assistive on-screen keyboard software for computers on the Windows operating system. It is designed to be used with a low cost eye-tracking device to enable speech and keyboard and mouse control to people with motor and speech limitations, such as amyotrophic lateral sclerosis (ALS) or…
Last week’s hot topic on ALS was an article titled Biohaven’s ALS Drug Candidate BHV-0223 Receives Positive FDA Feedback written by Magdalena Kegel. The article is focused on the recently announcement that Portage Biotech and Biohaven Pharmaceuticals have received positive feedback from the U.S.
https://www.youtube.com/watch?v=iGZxxppCVbM In this video by the Motor Neurone Disease Association, meet Alistair the Optimist. Learn more about ALS here: https://bit.ly/ALSNewsToday…
Motor neurodegeneration in amyotrophic lateral sclerosis (ALS) can begin in axons at neuromuscular junctions and later spread to the cell body in the spinal cord, in a phenomenon known as the “dying back” hypothesis. Proteins involved in axonal regeneration may, for this reason, represent a potential therapeutic target in ALS. A research team from Germany found…
In this video by Matthew Moore learn more about Steve’s ALS Fight. Learn more about ALS here: https://bit.ly/ALSNewsToday …
In this video by the Motor Neurone Disease Association, meet “Mark Maddox, the soccer player who made 300 appearances for Altrincham FC and now has motor neurone disease (MND).” Learn more about ALS here: https://bit.ly/ALSNewsToday…
Portage Biotech and Biohaven Pharmaceuticals recently announced they have received positive feedback from the U.S. Food and Drug Administration (FDA) on their Pre-Investigational New Drug Application (PIND) interaction regarding Biohaven’s investigative drug BHV-0223, intended for treatment of amyotrophic lateral sclerosis (ALS). BHV-0223 is the glutamate modulating compound riluzole, contained in the tablet…
“In recognition of Rare Disease Day 2016, Inspire CEO Brian Loew introduces the stories of members of Inspire’s online communities for people affected by rare disorders.” Learn more about ALS here: https://bit.ly/ALSNewsToday…
“ALS is a fatal, neurodegenerative disease that attacks nerve cells and pathways in the brain and spinal cord and slowly robs the body of its ability to speak, swallow and breathe. In the United States, a person is diagnosed with ALS every 90 minutes. The ALS Association St. Louis…
Get regular updates to your inbox.
